Cargando…

Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study

Although salvage liver transplantation (LT) has been widely adopted as a treatment for recurrent hepatocellular carcinoma(HCC), candidate selection criteria have not been established. This single-center study aimed to identify risk factors associated with HCC recurrence and survival following salvag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Pusen, Li, Hao, Shi, Baojie, Que, Weitao, Wang, Chunguang, Fan, Junwei, Peng, Zhihai, Zhong, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085210/ https://www.ncbi.nlm.nih.gov/pubmed/27145461 http://dx.doi.org/10.18632/oncotarget.9040

Ejemplares similares

Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study
por: Wang, Pusen, et al.
Publicado: (2016)

Impact of age on the prognosis after liver transplantation for patients with hepatocellular carcinoma: a single-center experience
por: Wang, Pusen, et al.
Publicado: (2015)

Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population
por: Jiang, Zhongyi, et al.
Publicado: (2021)

C7 genotype of the donor may predict early bacterial infection after liver transplantation
por: Zhong, Lin, et al.
Publicado: (2016)

Hepatic pannexin‐1 mediates ST2(+) regulatory T cells promoting resolution of inflammation in lipopolysaccharide‐induced endotoxemia
por: Wang, Pusen, et al.
Publicado: (2022)

CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target
por: Jiang, Qianwei, et al.
Publicado: (2023)

Efficacy and safety of a reduced calcineurin inhibitor dose combined with mycophenolate mofetil in liver transplant patients with chronic renal dysfunction
por: Wang, Pusen, et al.
Publicado: (2017)

Outcomes of salvage liver transplant for recurrent hepatocellular carcinoma: A comparison with primary liver transplant
por: Guo, Yuxin, et al.
Publicado: (2019)

Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma within UCSF Criteria after Liver Resection
por: Liu, Fei, et al.
Publicado: (2012)

Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection
por: Wu, LinWei, et al.
Publicado: (2012)

Immune Tolerance Induction Using Cell-Based Strategies in Liver Transplantation: Clinical Perspectives
por: Wang, Pusen, et al.
Publicado: (2020)

Different subpopulations of regulatory T cells in human autoimmune disease, transplantation, and tumor immunity
por: Jiang, Zhongyi, et al.
Publicado: (2022)

Systematic review of treatment strategy for recurrent hepatocellular carcinoma: Salvage liver transplantation or curative locoregional therapy
por: Wang, Hong-Liang, et al.
Publicado: (2019)

Retraction: Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection
Publicado: (2019)

Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment
por: Jiang, Zhongyi, et al.
Publicado: (2021)

Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma
por: Yadav, Dipesh Kumar, et al.
Publicado: (2018)

Salvage living donor liver transplantation for post-resection recurrence of combined hepatocellular carcinoma-cholangiocarcinoma
por: Kim, Minjae, et al.
Publicado: (2021)

Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria
por: Hu, Zhenhua, et al.
Publicado: (2014)

Retraction: Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria
Publicado: (2019)

PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma
por: Wang, Pusen, et al.
Publicado: (2020)

Salvage Liver Transplantation Leads to Poorer Outcome in Hepatocellular Carcinoma Compared with Primary Liver Transplantation
por: Shan, Yuhua, et al.
Publicado: (2017)

Microvascular invasion of hepatocellular carcinoma predicts microvascular invasion of its recurrence: potential implications for salvage liver transplantation?
por: Heinrich, Stefan, et al.
Publicado: (2022)

Salvage Liver Transplantation Is a Reasonable Option for Selected Patients Who Have Recurrent Hepatocellular Carcinoma after Liver Resection
por: Hu, Zhenhua, et al.
Publicado: (2012)

Repeat liver resection versus salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis
por: Guo, Yuxin, et al.
Publicado: (2019)

Salvage locoregional therapies for recurrent hepatocellular carcinoma
por: Criss, Cody R, et al.
Publicado: (2023)

Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation
por: Zhang, Tao, et al.
Publicado: (2017)

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Single-Center Experience
por: Zeair, Samir, et al.
Publicado: (2019)

Impact of multiple liver resections prior to salvage liver transplantation on survival in patients with recurrent HCC
por: Hu, Zhenhua, et al.
Publicado: (2015)

Albumin-bilirubin grade as a prognostic factor of hepatocellular carcinoma after treatment with orthotopic liver transplantation
por: Liao, Jianhua, et al.
Publicado: (2019)

Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma
por: Xing, Tonghai, et al.
Publicado: (2013)

The Role of Diverse Liver Cells in Liver Transplantation Tolerance
por: Jiang, Yanzhi, et al.
Publicado: (2020)

Prognostic Factors for Tumor Recurrence after a 12-Year, Single-Center Experience of Liver Transplantations in Patients with Hepatocellular Carcinoma
por: Cescon, Matteo, et al.
Publicado: (2010)

Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
por: Tang, Yunhua, et al.
Publicado: (2021)

Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio in Hepatocellular Carcinoma Patients Treated with Liver Transplantation
por: Li, Hui, et al.
Publicado: (2020)

The role of sorafenib in downsizing hepatocellular carcinoma prior to liver transplantation and in treating tumor recurrence
por: Sinakos, Emmanouil, et al.
Publicado: (2011)

Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
por: Rhu, Jinsoo, et al.
Publicado: (2018)

HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma
por: Xue, Feng, et al.
Publicado: (2015)

Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Chok, Kenneth S. H., et al.
Publicado: (2011)

Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Kim, Bo Hyun, et al.
Publicado: (2018)

Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: Pelizzaro, Filippo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dug71s967kh66bcfjkqgijfgkd